Table 2.
Regression coefficient | SE | Standardized regression coefficient (β) | t | P | |
---|---|---|---|---|---|
Hypoxanthine | |||||
Age | −0.018 | 0.004 | −0.175 | −4.27 | <0.001 |
Sex (male) | 0.001 | 0.063 | 0.001 | 0.02 | 0.988 |
Use of antihyperuricemic drugs | −0.098 | 0.185 | −0.021 | −0.53 | 0.595 |
Body mass index | 0.042 | 0.016 | 0.106 | 2.66 | 0.008 |
Smoking habit | 0.250 | 0.088 | 0.118 | 2.83 | 0.005 |
log Xanthine | 1.501 | 0.134 | 0.468 | 11.22 | <0.001 |
R 2 = 0.307 | |||||
log Xanthine | |||||
Age | 0.003 | 0.001 | 0.105 | 2.90 | 0.004 |
Sex (Male) | 0.017 | 0.018 | 0.034 | 0.92 | 0.357 |
Use of antihyperuricemic drugs | 0.275 | 0.051 | 0.192 | 5.37 | <0.001 |
log ALT | 0.173 | 0.052 | 0.163 | 3.30 | 0.001 |
Hypoxanthine | 0.141 | 0.011 | 0.456 | 12.59 | <0.001 |
log XOR | 0.130 | 0.029 | 0.215 | 4.51 | <0.001 |
R 2 = 0.416 | |||||
log XOR | |||||
Age | 0.003 | 0.002 | 0.052 | 1.58 | 0.115 |
Sex (Male) | −0.003 | 0.028 | −0.004 | −0.11 | 0.912 |
Use of antihyperuricemic drugs | −0.219 | 0.081 | −0.092 | −2.69 | 0.007 |
log ALT | 1.071 | 0.066 | 0.607 | 16.19 | <0.001 |
log Triglycerides | 0.179 | 0.052 | 0.119 | 3.41 | 0.001 |
log Xanthine | 0.198 | 0.061 | 0.119 | 3.22 | 0.001 |
R 2 = 0.489 | |||||
Uric acid | |||||
Age | −0.021 | 0.004 | −0.243 | −5.42 | <0.001 |
Sex (Male) | 0.505 | 0.050 | 0.396 | 10.09 | <0.001 |
Use of antihyperuricemic drugs | −0.025 | 0.143 | −0.007 | −0.17 | 0.862 |
Body mass index | 0.030 | 0.013 | 0.093 | 2.38 | 0.018 |
log ALT | 0.498 | 0.118 | 0.176 | 4.21 | <0.001 |
eGFR | −0.031 | 0.004 | −0.352 | −7.66 | <0.001 |
log Triglycerides | 0.277 | 0.094 | 0.115 | 2.94 | 0.003 |
R 2 = 0.358 |
ALT, alanine transaminase; eGFR, estimated glomerular filtration rate; SE, standard error; XOR, xanthine oxidoreductase.